Neurogene (NGNE) Accumulated Expenses: 2023-2025
Historic Accumulated Expenses for Neurogene (NGNE) over the last 2 years, with Sep 2025 value amounting to $9.4 million.
- Neurogene's Accumulated Expenses fell 9.71% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 9.71%. This contributed to the annual value of $9.7 million for FY2024, which is 44.38% down from last year.
- Neurogene's Accumulated Expenses amounted to $9.4 million in Q3 2025, which was up 3.59% from $9.1 million recorded in Q2 2025.
- Neurogene's 5-year Accumulated Expenses high stood at $17.5 million for Q4 2023, and its period low was $6.8 million during Q1 2024.
- Over the past 3 years, Neurogene's median Accumulated Expenses value was $9.3 million (recorded in 2025), while the average stood at $9.6 million.
- In the last 5 years, Neurogene's Accumulated Expenses slumped by 44.38% in 2024 and then rose by 27.34% in 2025.
- Quarterly analysis of 3 years shows Neurogene's Accumulated Expenses stood at $17.5 million in 2023, then tumbled by 44.38% to $9.7 million in 2024, then fell by 9.71% to $9.4 million in 2025.
- Its last three reported values are $9.4 million in Q3 2025, $9.1 million for Q2 2025, and $6.8 million during Q1 2025.